Olatec Therapeutics, Inc. ("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have been randomized in a 12-month ...
Abstract: This article presents a novel single-phase buck-boost ac–ac converter featuring a high-frequency built-in isolation transformer (HBIT). This topology offers several distinct advantages over ...
CHANGZHOU, JIANGSU, CHINA, March 20, 2026 /EINPresswire.com/ -- In the rapidly evolving landscape of haptic feedback ...
GUANGZHOU CITY, GUANGDONG PROVINCE, CHINA, March 19, 2026 /EINPresswire.com/ -- The global electric motor industry ...
Abstract: Electric mobility brings new challenges for electric traction motors in terms of energy efficiency and power density. Classic winding technologies for electric traction motors use round ...
ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy –– ARV-102 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results